New hospital garden in Boston to provide sanctuary to patients
A new hospital garden aims to provide a sanctuary for patients and staff according to the charity which helped to fund it.The garden has been opened at Pilgrim Hospital, in Boston, after being created by United Lincolnshire Teaching Hospitals NHS Trust.The trust previously opened a garden at Lincoln County Hospital last May and also one at Grantham and District Hospital in August.Jon Goodwin, head of grants at NHS Charities Together, said the garden cost about £50,000 to complete.
He said: "We're thrilled to see this wonderful garden open – just in time to see the spring bulbs still blooming."We know that getting outdoors in nature does wonders for both our physical and mental health, but we also know that this can be difficult for hospital patients and hard-working NHS staff."It's great that three hospitals across Lincolnshire, Grantham, Lincoln and Boston, now have green spaces like this, to be enjoyed by patients, staff and visitors alike."The gardens have been jointly funded by NHS Charities Together and the United Lincolnshire Hospitals Charity, to provide extra support for patients and staff that are not available through NHS budgets.
Ben Petts, the charity's manager, added the outdoor spaces can help people have "space alone with your thoughts or precious moments with loved ones".He said: "We all hope we will never need to visit hospital, but if we do – we all appreciate a small area of sanctuary where you can have space alone with your thoughts or precious moments with loved ones."A lot of thought and care has been put into these gardens by our contractors at SPA Landscaping and also by members of the working group."These areas really are going to make a massive difference for our patients, colleagues and visitors."Listen to highlights from Lincolnshire on BBC Sounds, watch the latest episode of Look North or tell us about a story you think we should be covering here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
29 minutes ago
- The Independent
Psychological support system opens to infected blood victims
Thousands of people impacted by the infected blood scandal in England will be able to self refer to a bespoke psychological support NHS service, officials have announced. The nationwide service began a phased rollout in September, and is now open to people infected and affected across the country. The Infected Blood Psychological Service will include talking therapies; peer support and psychosocial support, NHS England said. More than 30,000 people in the UK were infected with HIV and hepatitis C after they were given contaminated blood and blood products between the 1970s and early 1990s. And more than 3,000 people have died as a result, while survivors are living with lifelong health implications. The new service is open to victims of the scandal as well as bereaved partners, parents, children and their extended families. People can self refer by phone or can be referred to the service by their GP. Officials said that a specialist therapist will help create tailored mental health plans for those in need of support. Claire Murdoch, national mental health director at NHS England, said: 'The contaminated blood scandal and the subsequent long fight for answers have had life-altering physical and psychological impacts for thousands across the country and the NHS is determined to ensure that anyone infected or affected can receive evidence-based support and treatment. 'It has been so important that the Infected Blood Psychological Service has been co-designed with members of the infected blood community to ensure the best and most personalised care possible, and we are very grateful to all our partners who have helped establish these vital new services.' Nicola Leahey, from Lancashire, was infected with Hepatitis C following blood transfusions in 1975 and/or 1980, and was part of the expert advisory group to the new service. 'After my diagnosis, I felt that my body had been violated, that I had been physically and mentally abused, stripped of my dignity, my self-esteem diminished, I mourned lost opportunities, I felt betrayed,' she said. 'So many of us have long awaited the opportunity to have professional support to try to cope with the trauma and life-long effects that we've been subjected to. 'I'm thrilled that this much-needed service is now operational for both those infected and affected members of the infected blood community across England.' Professor Meghana Pandit, co-national medical director for secondary care at NHS England, added: 'Following the recommendations of the Inquiry, this new service represents a vital step in ensuring patients and families affected in England can be offered tailored psychological treatment and support, and we are pleased that specialist clinics are now open in all areas of England. 'This bespoke psychological treatment is already making a difference to the lives of the first people to access it, and we now want to ensure everyone eligible is aware of the services provided.'
The Herald Scotland
31 minutes ago
- The Herald Scotland
Women with genetic cancer risk being ‘missed' due to testing gaps
Lynch syndrome is a rare condition which runs in families which puts people at a higher risk of developing cancers of the bowel, womb and ovaries. It is caused by a mutation in the gene that fixes mistakes in DNA when it is copied, which can lead to uncontrolled cell growth. Patients with bowel or womb cancer should have their tumours assessed for markers of Lynch syndrome, according to guidance for the NHS. If these markers are identified, patients should be referred for genetic testing so the diagnosis can be confirmed and they can get support and advice about cancer risk for themselves and their family. A new study by academics at the University of Edinburgh found not all womb cancer patients are being sent for genetic testing. Researchers examined data on 2,500 womb cancer patients across the UK and Ireland between 2022 and 2023. We have launched a Guide to #LynchSyndrome to help provide information and support to anyone who thinks they may have it, that it may run in the family, or have found out they have — The Eve Appeal (@eveappeal) February 13, 2023 They found that 91% of tumours were tested for markers of Lynch syndrome, but the test results were not routinely communicated to the wider clinical team. This means that follow-up genetic counselling and blood tests were not always arranged. Of the 181 participants eligible for genetic counselling, just under two-thirds (64%) were referred for appointments, according to the study, which has been published in the journal BMJ Oncology. Researchers said those who were referred faced long waits, resulting in high dropout rates, meaning only 48% of those eligible went on to get the test. Today's #LynchSyndromeAwarenessDay. Our policy team sat down with our supporter, Jane, to share her experience. As well as highlighting what else needs to be done to improve Lynch syndrome care. Read our blog: — Bowel Cancer UK (@bowelcanceruk) March 22, 2025 Experts from the university said gaps in testing mean some womb cancer patients with Lynch syndrome go undetected. Family members are also left vulnerable to cancer risk, unaware they may have the condition. Dr Neil Ryan, from the University of Edinburgh, who leads the UK audit and research collaborative in obstetrics and gynaecology, said: 'Despite clear guidance and excellent rates of tumour testing, too many women with Lynch syndrome are still being missed because they're not referred for definitive blood testing in a timely way. 'This not only denies them the chance to reduce their future cancer risk but also prevents their relatives from being tested and protected. 'Tumour testing is only cost-effective if it leads to diagnosis — we urgently need to make mainstream testing truly mainstream.'
South Wales Argus
36 minutes ago
- South Wales Argus
Women with genetic cancer risk being ‘missed' due to testing gaps
A lack of testing for Lynch syndrome also means some cancer patients are unaware of their risk of developing other cancers, academics said. Lynch syndrome is a rare condition which runs in families which puts people at a higher risk of developing cancers of the bowel, womb and ovaries. It is caused by a mutation in the gene that fixes mistakes in DNA when it is copied, which can lead to uncontrolled cell growth. Patients with bowel or womb cancer should have their tumours assessed for markers of Lynch syndrome, according to guidance for the NHS. If these markers are identified, patients should be referred for genetic testing so the diagnosis can be confirmed and they can get support and advice about cancer risk for themselves and their family. A new study by academics at the University of Edinburgh found not all womb cancer patients are being sent for genetic testing. Researchers examined data on 2,500 womb cancer patients across the UK and Ireland between 2022 and 2023. We have launched a Guide to #LynchSyndrome to help provide information and support to anyone who thinks they may have it, that it may run in the family, or have found out they have — The Eve Appeal (@eveappeal) February 13, 2023 They found that 91% of tumours were tested for markers of Lynch syndrome, but the test results were not routinely communicated to the wider clinical team. This means that follow-up genetic counselling and blood tests were not always arranged. Of the 181 participants eligible for genetic counselling, just under two-thirds (64%) were referred for appointments, according to the study, which has been published in the journal BMJ Oncology. Researchers said those who were referred faced long waits, resulting in high dropout rates, meaning only 48% of those eligible went on to get the test. Today's #LynchSyndromeAwarenessDay. Our policy team sat down with our supporter, Jane, to share her experience. As well as highlighting what else needs to be done to improve Lynch syndrome care. Read our blog: — Bowel Cancer UK (@bowelcanceruk) March 22, 2025 Experts from the university said gaps in testing mean some womb cancer patients with Lynch syndrome go undetected. Family members are also left vulnerable to cancer risk, unaware they may have the condition. Dr Neil Ryan, from the University of Edinburgh, who leads the UK audit and research collaborative in obstetrics and gynaecology, said: 'Despite clear guidance and excellent rates of tumour testing, too many women with Lynch syndrome are still being missed because they're not referred for definitive blood testing in a timely way. 'This not only denies them the chance to reduce their future cancer risk but also prevents their relatives from being tested and protected. 'Tumour testing is only cost-effective if it leads to diagnosis — we urgently need to make mainstream testing truly mainstream.'
